Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency

BACKGROUND: Bilastine is a novel second-generation H(1) antihistamine, which has not shown sedative or cardiotoxic effects in clinical trials and in post-marketing experience so far, developed for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. It has recently been granted m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasseter, Kenneth C., Sologuren, Ander, La Noce, Anna, Dilzer, Stacy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751212/
https://www.ncbi.nlm.nih.gov/pubmed/23873362
http://dx.doi.org/10.1007/s40261-013-0110-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751212/
https://www.ncbi.nlm.nih.gov/pubmed/23873362
http://dx.doi.org/10.1007/s40261-013-0110-0

Ejemplares similares